Search Results 161-170 of 34159 for oral

1. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With Myoclonic-Atonic Seizures - Mayo Clinic

   Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With ...

2. Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients

   SAN DIEGO — Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and ...

3. Jaw surgery - Care at Mayo Clinic

   Mayo Clinic oral, jaw and face surgeons (maxillofacial surgeons) and orthodontists have vast experience in treating complex jaw conditions. They have ...

4. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

5. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

6. A Study Comparing Treatment with Oral Solution versus the Standard Intravenous Fluid Therapy for Acute Dehydration in Adults - Mayo Clinic

   The purpose of this study is to compare the efficiency and patient acceptability of treatment with an oral rehydration solution versus the standard intravenous ...

7. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

   A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.

8. Ondansetron (oral route, oromucosal route) - Mayo Clinic

   For oral dosage forms (oral disintegrating tablets, solution, or tablets):. For prevention of moderate nausea and vomiting after treatment with cancer ...

9. Oral and Maxillofacial Surgery Residency, M.D.-O.M.S. (Minnesota) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

   Mayo Clinic School of Graduate Medical Education offers a six-year Oral and Maxillofacial Surgery Residency in Rochester, Minnesota.

10. Study To Evaluate The Efficacy And Safety Of Oral Rilzabrutinib In Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment - Mayo Clinic

    Study To Evaluate The Efficacy And Safety Of Oral Rilzabrutinib In Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment · Overview.